Patents by Inventor Nalini M

Nalini M has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110263488
    Abstract: Compositions and methods for conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions comprising a coding sequence for pesticidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated pesticidal nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed.
    Type: Application
    Filed: June 24, 2011
    Publication date: October 27, 2011
    Applicant: ATHENIX CORP.
    Inventors: Nadine Carozzi, Michael G. Koziel, Nicholas B. Duck, Nalini M. Desai, Rong Guo, Daniel John Tomso, Rebekah Deter, Tracy Hargiss
  • Publication number: 20080300184
    Abstract: Materials and Methods related to a transgenic non-human animal (e.g., a transgenic non-human mammal) whose genome comprises a disrupted TIEG allele are provided. Methods for making such transgenic non-human animals, and using them to identify and characterize agents that affect conditions related to TIEG activity, such as cardiac hypertrophy and bone formation also are provided. In addition, materials and methods related to the treatment of hypertrophic cardiomyopathy are provided.
    Type: Application
    Filed: October 5, 2007
    Publication date: December 4, 2008
    Inventors: Thomas C. Spelsberg, Malayannan Subramaniam, Merry Jo Velasquez, Nalini M. Rajamannan
  • Patent number: 7304203
    Abstract: Materials and methods related to a transgenic non-human animal (e.g., a transgenic non-human mammal) whose genome comprises a disrupted TIEG allele are provided. Methods for making such transgenic non-human animals, and using them to identify and characterize agents that affect conditions related to TIEG activity, such as cardiac hypertrophy and bone formation also are provided. In addition, materials and methods related to the treatment of hypertrophic cardiomyopathy are provided.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: December 4, 2007
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Thomas C. Spelsberg, Malayannan Subramaniam, Merry Jo Velasquez, Nalini M. Rajamannan
  • Publication number: 20040058444
    Abstract: The invention provides methods and materials related to heart valves and the treatment of valvular heart disease. Specifically, the invention provides non-murine heart valve cells and heart valve cusps as well as methods for making heart valves. The invention also provides methods and materials for (1) slowing heart valve degeneration, thrombosis, and calcification, (2) treating carcinoid heart disease, (3) identifying inhibitors of heart valve degeneration, thrombosis, and calcification, and (4) determining the safety of drugs.
    Type: Application
    Filed: September 22, 2003
    Publication date: March 25, 2004
    Inventor: Nalini M. Rajamannan
  • Patent number: 6660260
    Abstract: The invention provides methods and materials related to heart valves and the treatment of valvular heart disease. Specifically, the invention provides non-murine heart valve cells and heart valve cusps as well as methods for making heart valves. The invention also provides methods and materials for (1) slowing heart valve degeneration, thrombosis, and calcification, (2) treating carcinoid heart disease, (3) identifying inhibitors of heart valve degeneration, thrombosis, and calcification, and (4) determining the safety of drugs.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: December 9, 2003
    Assignee: Mayo Foundation for Medical Education and Research
    Inventor: Nalini M. Rajamannan
  • Patent number: 6534538
    Abstract: The present invention involves a method for slowing heart valve degeneration in which an inhibitor of hydroxymethylglutaryl CoA reductase is administered.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: March 18, 2003
    Assignee: Mayo Foundation for Medical Education and Research
    Inventor: Nalini M. Rajamannan
  • Publication number: 20020159983
    Abstract: The invention provides methods and materials related to heart valves and the treatment of valvular heart disease. Specifically, the invention provides non-murine heart valve cells and heart valve cusps as well as methods for making heart valves. The invention also provides methods and materials for (1) slowing heart valve degeneration, thrombosis, and calcification, (2) treating carcinoid heart disease, (3) identifying inhibitors of heart valve degeneration, thrombosis, and calcification, and (4) determining the safety of drugs.
    Type: Application
    Filed: December 21, 2001
    Publication date: October 31, 2002
    Applicant: Mayo Foundation for Medical Education and Research , a Minnesota corporation
    Inventor: Nalini M. Rajamannan
  • Patent number: 6403865
    Abstract: Methods for transformation of maize with nucleic acid sequences of interest are disclosed. The method involves subjecting immature zygotic embryos or Type I callus to high velocity microprojectile bombardment. The method is capable of producing transformed maize lines of commercial importance and their hybrid combinations.
    Type: Grant
    Filed: May 10, 1995
    Date of Patent: June 11, 2002
    Assignee: Syngenta Investment Corp.
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Vance C. Kramer, Gregory W. Warren, Stephen V. Evola, Lyle D. Crossland, Martha S. Wright, Ellis J. Merlin, Karen L. Launis, Steven J. Rothstein, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie, Nadine Carozzi, Annick De Framond, James O. Linder, Robert L. Miller, Bruce W. Skillings, Alan W. Mousel, Albert R. Hornbrook, Christopher P. Clucas, Moez Rajabali Meghji, Andreas H. Tanner, Francis E. Cassagne, Gilles Pollini, Terry Ray Colbert, Francis P. Cammack
  • Patent number: 6320100
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: April 11, 2000
    Date of Patent: November 20, 2001
    Assignee: Syngenta Investments, Inc.
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Gregory W. Warren, Stephen V. Evola, Martha S. Wright, Karen L. Launis, Steven J. Rothstein, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 6278041
    Abstract: A anionic peroxidase gene sequence is isolated from Nicotiana tomentisiformis. In addition, synthetic Nicotiana tomentisiformis and Nicotiana sylvestris peroxidase gene sequences are optimized for expression in plants. The peroxidase gene sequences may be expressed in transgenic plants to control insects.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: August 21, 2001
    Assignee: Syngenta Participations AG
    Inventors: Lawrence Mark Lagrimini, Nalini M Desai
  • Patent number: 6172039
    Abstract: The invention is directed to a substantially pure mammalian globin chain or heme-binding fragment thereof. The invention is further directed to recombinant DNA vectors capable of expressing at least one globin chain or substantially homologous variant thereof in yeast. The invention also relates to methods for expressing at least one globin chain or substantially homologous variant thereof in yeast. Expressed alpha-like globin and beta-like globin chains or variants thereof may be combined with a source of heme to produce hemoglobin or a substantially homologous variant thereof. Additionally, expressed gamma-globin chains may be combined with a source of heme to produce hemoglobin or a substantially homologous variant thereof. The invention also relates to methods for expressing hemoglobin or variants thereof in yeast where the heme is produced by the yeast and ligated to globins to form hemoglobin in vivo.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 9, 2001
    Assignee: Apex Bioscience, Inc.
    Inventors: Joseph De Angelo, Nalini M. Motwani, Wajeeh Bajwa, Joseph Bonaventura
  • Patent number: 6137033
    Abstract: The genes encoding a novel class of insectecidal proteins have been isolated and characterized from a strain of Bacillus thuringiensis. Both the nucleic and amino acid sequences for the proteins are disclosed. The nucleic acid molcules are utilized in the transformation of host microorganisms and production of trangenic plants which are resistant to insects. Also, the gene encoding for the insect's receptor of the insecticide protein has been isolated and characterized. Novel processes and methods for controlling plants pests are provided.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: October 24, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Juan J. Estruch, Gregory W. Warren, Nalini M. Desai, Michael G. Koziel, Gordon J. Nye
  • Patent number: 6121014
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: September 19, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis
  • Patent number: 6121521
    Abstract: The present invention describes the design and construction of a chimeric insecticidal protein by joining the 5' portion of a synthetic maize optimized cry1B gene (SFLIB) to the 3' end of a full-length synthetic maize optimized cry1A(b) gene to generate a full-length hybrid cry1B gene (hyFLIB). When the chimeric insecticidal protein gene is expressed in transgenic maize from both PEPC and pith promoters, insecticidal activity is observed in transgenic maize tissue against European corn borer (Ostrinia nubilalis). An additional aspect of the invention is recombinant, biologically pure microbial strains transformed with the hyFLIB gene which can be used in entomocidal formulations for the control of Lepidopteran insects. Yet another aspect of the invention is plants transformed with the toxin gene or active fragments thereof, particularly where the transforming sequences have been optimized for expression in maize.
    Type: Grant
    Filed: April 1, 1998
    Date of Patent: September 19, 2000
    Assignee: Novartis AG
    Inventor: Nalini M. Desai
  • Patent number: 6107279
    Abstract: The genes encoding a novel class of insecticidal proteins have been isolated and characterized from a strain of Bacillus thuringiensis. Both the nucleic and amino acid sequences for the proteins are disclosed. The nucleic acid molecules are utilized in the transformation of host microorganisms and production of transgenic plants which are resistant to insects. Also, the gene encoding for the insect's receptor of the insecticidal protein has been isolated and characterized. Novel processes and methods for controlling plants pests are provided.
    Type: Grant
    Filed: January 20, 1999
    Date of Patent: August 22, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Juan J. Estruch, Cao-Guo Yu, Gregory W. Warren, Nalini M. Desai, Michael G. Koziel, Gordon J. Nye
  • Patent number: 6075185
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: June 13, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Gregory W. Warren, Stephen V. Evola, Martha S. Wright, Karen L. Launis, Steven J. Rothstein, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 6066783
    Abstract: The present invention is drawn to pesticidal strains and proteins. Bacillus strains which are capable of producing pesticidal proteins and auxiliary proteins during vegetative growth are provided. Also provided are the purified proteins, nucleotide sequences encoding the proteins and methods for using the strains, proteins and genes for controlling pests.
    Type: Grant
    Filed: April 27, 1999
    Date of Patent: May 23, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Gregory W. Warren, Michael G. Koziel, Martha A. Mullins, Gordon J. Nye, Brian Carr, Nalini M. Desai, Kristy Kostichka
  • Patent number: 6051760
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: April 18, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Gregory W. Warren, Stephen V. Evola, Martha S. Wright, Karen L. Launis, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 6018104
    Abstract: DNA sequences optimized for expression in plants are disclosed. The DNA sequences preferably encode for an insecticidal polypeptides, particularly insecticidal proteins from Bacillus thuringiensis. Plant promoters, particular tissue-specific and tissue-preferred promoters are also provided. Additionally disclosed are transformation vectors comprising said DNA sequences. The transformation vectors demonstrate high levels of insecticidal activity when transformed into maize.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 25, 2000
    Assignee: Novartis Finance Corporation
    Inventors: Michael G. Koziel, Nalini M. Desai, Kelly S. Lewis, Vance C. Kramer, Gregory W. Warren, Stephen V. Evola, Martha S. Wright, Karen L. Launis, Steven J. Rothstein, Cindy G. Bowman, John L. Dawson, Erik M. Dunder, Gary M. Pace, Janet L. Suttie
  • Patent number: 5990383
    Abstract: The present invention is drawn to pesticidal strains and proteins. Bacillus strains which are capable of producing pesticidal proteins and auxiliary proteins during vegetative growth are provided. Also provided are the purified proteins, nucleotide sequences encoding the proteins and methods for using the strains, proteins and genes for controlling pests.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 23, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Gregory W. Warren, Michael G. Koziel, Martha A. Mullins, Gordon J. Nye, Brian Carr, Nalini M. Desai, Kristy Kostichka, Nicholas B. Duck, Juan J. Estruch